These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 15100386

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Identification of alpha-1L and alpha-1A adrenoceptors in human prostate by tissue segment binding.
    Morishima S, Tanaka T, Yamamoto H, Suzuki F, Akino H, Yokoyama O, Muramatsu I.
    J Urol; 2007 Jan; 177(1):377-81. PubMed ID: 17162094
    [Abstract] [Full Text] [Related]

  • 3. Alpha-1 adrenoceptors: evaluation of receptor subtype-binding kinetics in intact arterial tissues and comparison with membrane binding.
    Tanaka T, Zhang L, Suzuki F, Muramatsu I.
    Br J Pharmacol; 2004 Feb; 141(3):468-76. PubMed ID: 14718262
    [Abstract] [Full Text] [Related]

  • 4. RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification.
    Ford AP, Arredondo NF, Blue DR, Bonhaus DW, Jasper J, Kava MS, Lesnick J, Pfister JR, Shieh IA, Vimont RL, Williams TJ, McNeal JE, Stamey TA, Clarke DE.
    Mol Pharmacol; 1996 Feb; 49(2):209-15. PubMed ID: 8632751
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.
    Murata S, Taniguchi T, Muramatsu I.
    Br J Pharmacol; 1999 May; 127(1):19-26. PubMed ID: 10369451
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological characterization and cross talk of alpha1a- and alpha1b-adrenoceptors coexpressed in human embryonic kidney 293 cells.
    Israilova M, Tanaka T, Suzuki F, Morishima S, Muramatsu I.
    J Pharmacol Exp Ther; 2004 Apr; 309(1):259-66. PubMed ID: 14722320
    [Abstract] [Full Text] [Related]

  • 7. Native profiles of alpha(1A)-adrenoceptor phenotypes in rabbit prostate.
    Su TH, Morishima S, Suzuki F, Yoshiki H, Anisuzzaman AS, Tanaka T, Cheng JT, Muramatsu I.
    Br J Pharmacol; 2008 Nov; 155(6):906-12. PubMed ID: 18695643
    [Abstract] [Full Text] [Related]

  • 8. Expression of distinct alpha 1-adrenoceptor phenotypes in the iris of pigmented and albino rabbits.
    Muramatsu I, Suzuki F, Nishimune A, Anisuzzaman AS, Yoshiki H, Su TH, Chang CK, Morishima S.
    Br J Pharmacol; 2009 Sep; 158(1):354-60. PubMed ID: 19466984
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of an alpha 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat.
    Lachnit WG, Tran AM, Clarke DE, Ford AP.
    Br J Pharmacol; 1997 Mar; 120(5):819-26. PubMed ID: 9138687
    [Abstract] [Full Text] [Related]

  • 11. Tissue selectivity of KMD-3213, an alpha(1)-adrenoreceptor antagonist, in human prostate and vasculature.
    Murata S, Taniguchi T, Takahashi M, Okada K, Akiyama K, Muramatsu I.
    J Urol; 2000 Aug; 164(2):578-83. PubMed ID: 10893647
    [Abstract] [Full Text] [Related]

  • 12. Identification of alpha 1L-adrenoceptor in mice and its abolition by alpha 1A-adrenoceptor gene knockout.
    Muramatsu I, Morishima S, Suzuki F, Yoshiki H, Anisuzzaman AS, Tanaka T, Rodrigo MC, Myagmar BE, Simpson PC.
    Br J Pharmacol; 2008 Dec; 155(8):1224-34. PubMed ID: 18806813
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological characterization of alpha 1-adrenoceptor subtypes in rat heart: a binding study.
    Noguchi H, Muraoka R, Kigoshi S, Muramatsu I.
    Br J Pharmacol; 1995 Mar; 114(5):1026-30. PubMed ID: 7780636
    [Abstract] [Full Text] [Related]

  • 14. Identification of binding sites of prazosin, tamsulosin and KMD-3213 with alpha(1)-adrenergic receptor subtypes by molecular modeling.
    Ishiguro M, Futabayashi Y, Ohnuki T, Ahmed M, Muramatsu I, Nagatomo T.
    Life Sci; 2002 Oct 11; 71(21):2531-41. PubMed ID: 12270758
    [Abstract] [Full Text] [Related]

  • 15. Two distinct alpha 1-adrenoceptor subtypes in rabbit liver: a binding study.
    Ohmura T, Muramatsu I.
    Br J Pharmacol; 1995 Nov 11; 116(6):2591-6. PubMed ID: 8590975
    [Abstract] [Full Text] [Related]

  • 16. Visualization and tissue distribution of alpha1L-adrenoceptor in human prostate by the fluorescently labeled ligand Alexa-488-silodosin.
    Morishima S, Suzuki F, Nishimune A, Yoshiki H, Akino H, Yokoyama O, Muramatsu I.
    J Urol; 2010 Feb 11; 183(2):812-9. PubMed ID: 20034639
    [Abstract] [Full Text] [Related]

  • 17. [Alpha1-adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213)].
    Tatemichi S, Kobayashi K, Maezawa A, Kobayashi M, Yamazaki Y, Shibata N.
    Yakugaku Zasshi; 2006 Mar 11; 126 Spec no.():209-16. PubMed ID: 16518085
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vivo demonstration of alpha(1A)-adrenoceptor subtype selectivity of KMD-3213 in rat tissues.
    Yamada S, Okura T, Kimura R.
    J Pharmacol Exp Ther; 2001 Jan 11; 296(1):160-7. PubMed ID: 11123376
    [Abstract] [Full Text] [Related]

  • 20. Quantitative imaging in live human cells reveals intracellular alpha(1)-adrenoceptor ligand-binding sites.
    Mackenzie JF, Daly CJ, Pediani JD, McGrath JC.
    J Pharmacol Exp Ther; 2000 Aug 11; 294(2):434-43. PubMed ID: 10900216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.